061111 HyperPP - PPA Presentation
-
Upload
sarwenda-annas -
Category
Documents
-
view
214 -
download
0
Transcript of 061111 HyperPP - PPA Presentation
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 1/34
Hyperkalemic Periodic Paralysis
Preliminary Survey Results
&
ManagementGuidelines
Grace Charles, Chengjie Zheng,
Jacob Levitt, MD
The Mount Sinai School of Medicine, NY
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 2/34
Contents
• History of HyperPP
• Intro to HyperPP
• Signs & Symptoms
•
Our study: addressesthese gray areas
– General Information
– Diagnosis & Symptoms
– Treatment and
Management
– Special Situations andConclusion
• Prevention
• Management
• Ideas
•
Special Situations• Tips from Fellow
HyperPPers
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 3/34
History of HyperPP
• 1st family identified 60 years ago – Episodes: frequent short attacks of paralysis
– Triggers: rest after exercise, stress, and certain foods
– Genetics: autosomal dominant, complete penetrance
– Reference: Tyler et al, 1951
• 2nd family 5 years later – K+ levels were high in some members
– K+ administration precipitated attacks
– Reference: Gamstorp, 1956
• These two reports clearly distinguished hyperPP from the more
common hypokalemic periodic paralysis
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 4/34
Intro to HyperPP
• What: episodes of muscleweakness – Induced by increased K+ levels
– +/- paramyotonia congenita
(PMC)• Why: autosomal dominant
hyper = high
kalemia = blood potassium level periodic = occurring at intervals
paralysis = loss of ability to move
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 5/34
Intro to HyperPP
• How: mutated skeletal muscle sodium channel
• Who: onset in infancy or early childhood; prevalence1:200,000; M = F
• When/where: usually triggered by cold exposure, restafter exercise, fasting, stress, ingestion of potassium,e.g. bananas or orange juice, or anesthesia
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 6/34
Signs & Symptoms
• Attacks of weakness
– Focal, affecting one limb, OR generalized flaccid
paralysis
– Spares consciousness, cranial muscles, respiration
– +/- muscle pain with attacks
– +/- arrhythmias from high K+
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 7/34
Signs & Symptoms
• +/- Myotonia between attacks
– Myotonia: delayed muscle relaxation after
contraction (i.e., stiffness/rigidity)
• Adolescence/early adulthood:
– Attacks most frequent
• Between ages 30 and 60:
– Attacks decrease in frequency
– Permanent muscle weakness
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 8/34
Our Survey
• Recruitment through PPA, PPA medical advisors
• 4 main categories of questions
– General Information
– Diagnosis & Symptoms – Treatment and Management
– Special Situations and Conclusion
• 72 responses 43 documented mutations, fromUSA, Canada, Germany, India, Singapore
– Some participants chose not to answer certainquestions so not all questions had 43 responses
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 9/34
Respondent Characteristics
Diagnosis HyperKPP (22)HyperKPP with paramyotonia congenita (21)
Age 0-20 (3) 21-30 (6) 31-40 (8) 41-50 (11) 51-60 (5) 61+ (10)
Sex Male (21) Female
(20)
Blank (2)
Family
History
Child (25)
Maternal grandparent (21)
Aunt/Uncle (16)
Sibling (14)
Parent (9)Grandchild (9)
Paternal grandparent (4)
All mutation-positive respondents had family history of
HyperKPP
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 10/34
Comorbidities:(? Due to no exercise & high carbs?)
• High triglycerides/cholesterol (7)
• Thyroid problems (7)
• High blood pressure (4)
• Migraines (4)
• CAD (3)
• Arrhythmias (3)
• DM2 (3)
• Kidney problems (2)
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 11/34
Diagnosis
Age at first
attack0-1 yrs (13) 2-10 yrs (18) 11-20 yrs (5)
Time to
diagnosis
(~50% > 7 yrs)
< 1 yr (5) 1-5 yrs (2) 7-10 yrs (5) >11 yrs (15)
Specialists
• 29/43 (~70%) saw 2-3 physicians before diagnosis
• Neurologists were felt to be most valuable (rated
4.5/5)
Misdiagnoses(~40%)
Malingering/Faking it
(8)
Conversiondisorder
(4)
HypoKPP(3)
Depression(1)
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 12/34
Attack Characteristics
Warning
period
<60 min (30)
1-5h (3)
Type of
attacks
Weakness + stiffness (27)
Primarily weakness (26)
Primarily stiffness (17)
Body parts Partial body (19)
Total body (11)
Only muscles used prior to attack (9)
Severity ofattacks/
function
Mild (15)Moderate (21)
Severe (5)
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 13/34
Attack Characteristics, continued
Frequency <1-3 X/month (15)
1-6 X/week (13)
1-4 X/day (9)
Duration <1 hour (12)1-4 hours (7)
20+ hours (8)
Time of day Morning (20)
Upon waking (14)During sleep (18)
Afternoon (9) Evening (6)
Night (10)
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 14/34
Areas Affected by Attacks
0
5
10
15
20
25
30
35
40
s p e a k i n g
m u s c u l a t u r e
b r e a t h i n g
m u s c u l a t u r e
f a c e
e y e l i d s
n e c k
a r m s
h a n d s
h i p s
t h i g h
c a l f
f e e t
N u m b e r o f R e
s p o n d e n t s
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 15/34
Associated Symptoms
0
5
10
15
20
25
N u m b n e s s /
t i n g l i n g
S w e a t i n g
P a l p i t a t i o n s
S h o r t n e s s o f
b r e a t h / D i f f i c u l t y
b r e a t h i n g
L o s s o f
b l a d d e r c o n t r o l
L o s s o f
b o w e l c o n t r o l
N u m b e r o f r e s p o n d e n t s
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 16/34
Symptoms Surrounding Attacks
• Symptoms After Attacks – Muscle Pain (56%) (N=24)
– Clumsiness (35%) (N=15)
– Extreme fatigue (30%) (N=13)
– Irritability (30%) (N=13)
– Mental dullness (14%) (N=6)
• Mood Around Attacks (~30-40%) – Irritable (17) – Lethargic (15)
– Depressed (12)
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 17/34
Triggers for Attacks
0
5
1015
20
25
30
35
R e s t a f t e r e x
e r c i s e
H
u n g e r
S p e c i f i c f o o d s / b e v e
r a g e s
A l c o h o l
C o l d
C h a n g e i n h u m i d i t y
S i c
k n e s s
E x t r a
s l e e p
S t r e s s / f a t i g u e
M e d i c a t i o n s
M e n s t r u a l c y c l e
P r e g
n a n c y
C h a n g e s i n a c t i v i t y l e v e l
P o t a s s i u m i
n f o o d
P o t a s s i u m s
u p p l e m e n t s
N u m b e r o
f r e s p o n d e n t s
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 18/34
Disease Effects
WeightWeight gain (16)
(37%)No effect (25)
Progressive
myopathy
Yes (13)
(30%) No (17) Unsure (12)
Hypokalemic
weaknessNo (20)
Yes (7)
(16%)
Effects on
aspects of life
Mental health (14)
Physical health
(21)
Family life (20)
Relationships (11)
Work (27)
School (19)
M di ti M t
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 19/34
Medication ManagementMedications
for acute
attacks
None (5)
Diuretics* (5)
Magnesium (4)
Beta-2 agonists* (4)
Antiarrhythmics* (3)
Anticonvulsants (2)
Potassium (2)
Glucose tablets (2)
Ability to
abort
attacks
All of the time (0)
Most of the time
(12)
Some of the time
(12)
Occasionally (5)
Never (9)
Chronicmedications Diamox (12)HCTZ (10)
Salbutamol (6)
Mexitil (5)Daranide (2)
Glucose tablets (1)
Lasix (1)IV Ca gluconate (0)
Level of
control
Needs
improvement (15)
Mostly controlled
(15)
Optimal (2)
Time to
regimen
<2 years (3) 2-4 years (2) 9-20 years (4)
Rx to avoid (Open-Ended ): Potassium, corticosteroids, antibiotics, statins,
diuretics
*Diuretics: HCTZ, Diamox, Daranide, torsemide, Lasix*Beta-2 agonists: salbutamol, fenoterol
*Antiarrhythmics: propafenone, flecainide, Mexitil*Anticonvulsants: Lamictal, Topamax, Trileptil, carbamazepine
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 20/34
Dietary ManagementMeal frequency 1 meal per day (0)
2 meals per day (2)
3 meals per day (9)
4 meals per day (6)
5 meals per day (2)
6 meals per day (1)
Frequency of
carbohydrate-
rich snacks
Never (1)
Every 2 hours (1)
Every 2.5-3 hours (4)Food quantity Small (4)
Medium (18)
Large (4)
Faster response
with liquid vs.
solid sweets
Liquid sweets (9)
Solid sweets (3)
No difference/ have not noticed (17)
Foods to avoid Bananas (15)
Alcohol (10)
Diet soda (6)
Dried figs (6)
Tomato/vegetable juices (5)
Apricots (5)
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 21/34
Helpful Foods
0
2
4
6
8
10
12
14
16
N u m b e r o f r e s p o n d e n t s
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 22/34
Other Management
Acute management Keeping warm (17)Sugary food (12)
Gentle exercise (3)
Home
accommodations
None (19)
Items kept within reach near bed (11)
Exercise equipment (5)Rug placement (4)
Bathroom railings (4)
Emergency access button or necklace (1)
Wheelchair accessibility (1)
Exercise Walking (17)Yoga (3)
Swimming (5)
Biking (8)
Jogging/Running (3)
Aerobic exercise (3)
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 23/34
Special Situations
Pregnancy
More severe (4) Less severe (6)Same
severity (7)
More frequent(7) Less frequent (4) Samefrequency (6)
Local
anesthesia
Did not trigger
attack (27)
Triggered attack
(4)
General
anesthesia
Did not trigger
attack (18)
Triggered attack
(9)
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 24/34
Prevention: Diet
• Avoid foods rich in potassium
– Fruits, fruit juices
• Avoid medications that elevate
potassium levels
– Spironolactone, enalapril, valsartan
• Avoid fasting
• Some find that high salt intake reduces
attack frequency & severity
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 25/34
Prevention: Activity
• Exercise
• Unclear how to advise
• Some individuals find that continuing mild exercise
after a period of more vigorous exercise can lessen anattack
• Avoid exposure to cold
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 26/34
Prevention: Chronic Therapy
• Helpful medications:
– Thiazide diuretics
– Acetazolamide
– Albuterol inhaler (1 to 2 puffs of 0.1 mg)
– Your physician should monitor your electrolyte
levels to ensure they remain in a safe range
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 27/34
Management of Acute Attacks
• MILD - abort or prevent attacks at onset with:
– sugar
– mild exercise
• MODERATE/SEVERE – abort with:
– thiazide diuretics (hydrochlorothiazide)
– inhaled beta adrenergic agonists (salbutamol)
– intravenously injected glucocorticoids?
– intravenous calcium gluconate [for heart]
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 28/34
Hypotheses
• Treadmill at home: exercise but help will be
near
• Pace workout: use music for slow rhythm to
limit overexertion
• Meditation CD: prevent a stress-induced
attack when feeling overwhelmed or tense
• Tiger Balm or Advil: for post-attack muscle
stiffness and soreness
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 29/34
Special Situations: Surgery
• Make anesthesia staff aware of diagnosis
• Opioids or depolarizing agents used in anesthesia myotonia
interfere with intubation / ventilation
• Breathing problems / weakness when recovering from general
anesthesia
– Prevent carbohydrate depletion – D5W is good!
– Avoid muscle relaxants
– Maintain a normal body temperature
– Keep serum potassium levels from being elevated
• Asymptomatic family members should be tested for the
family’s mutation before surgery so preventive measures can
be instituted
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 30/34
Special Situations
• When you change routine, such as sleeping
late on holidays or weekends, attacks can
occur more frequently
– Wake up at your usual hour and have your regular
breakfast meal
• Albuterol is safe in pregnancy
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 31/34
Tips from Fellow HyperPPers
• Know what works for you
• Get all the support possible
•
Don't be afraid to talk about it• Stand up for your rights
• Learn all you can
•Diagnosis is a long road, but…
• Get diagnosed!
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 32/34
Tips from Fellow HyperPPers
• Know what works for you. My son & I both have pp but havedifferent severity and longevity.
• Get regular exercise, eat frequent small meals, reduce stress.
• Do not sit for longer period. Keep moving. Never skip food. Do notdo heavy exercise.
• Expect that most doctors you see are not going to believe you. But itis real, there are many people who have it and it can be managed.
• I spent many years being dismissed by various doctors for mysymptoms. It takes a long time to find someone who has heard ofthese conditions, and then figuring out how to manage them isanother long road .
• Get diagnosed
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 33/34
Tips from Fellow HyperPPers
• Don't wait to find out as much as you can. I was misdiagnosed forover 40 years with hypo and it has now affected my health
• Get all the support possible , and don't be afraid to talk about it ;stand up for your rights and don't put yourself in a situation youknow you will suffer in.
•Don't lie about it, explain to others what it is (which in mychildhood/teen years was impossible because no one knew what itwas). Join the PP list to share experiences with others and learn from them.
• Learn all you can! Talk with others, learn how to manage your diet.You can take control of many things, even though mid-attack you
have little to no control. When you're feeling strong - go out and dothings! Don't put things off, because you never know when the nextbig attack might come. We already must suffer being paralyzed physically, so let's not be paralyzed by fear, as well.
7/23/2019 061111 HyperPP - PPA Presentation
http://slidepdf.com/reader/full/061111-hyperpp-ppa-presentation 34/34
Questions?